116 related articles for article (PubMed ID: 10657035)
1. Anatomical distribution of sodium-dependent [(3)H]naloxone binding sites in rat brain.
Sim-Selley LJ; Xiao R; Childers SR
Synapse; 2000 Mar; 35(4):256-64. PubMed ID: 10657035
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
3. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
[TBL] [Abstract][Full Text] [Related]
4. Sulfhydryl groups on opioid receptors revisited. Evidence for two sulfhydryl groups at or near the active site of the mu opioid receptor.
Ofri D; Simon EJ
Receptor; 1992; 2(2):109-19. PubMed ID: 1335327
[TBL] [Abstract][Full Text] [Related]
5. Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain.
Talbot JN; Happe HK; Murrin LC
J Pharmacol Exp Ther; 2005 Aug; 314(2):596-602. PubMed ID: 15860573
[TBL] [Abstract][Full Text] [Related]
6. Quantitative autoradiography of Gpp(NH)p sensitive and insensitive [3H]quinpirole binding sites in the rat brain.
Gehlert DR
Synapse; 1993 Jun; 14(2):113-20. PubMed ID: 8101393
[TBL] [Abstract][Full Text] [Related]
7. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5'-yl imidodiphosphate.
Wong CS; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1994 Feb; 268(2):653-61. PubMed ID: 8113975
[TBL] [Abstract][Full Text] [Related]
8. Interaction of opiate receptor binding sites and guanine nucleotide regulatory sites: selective protection from N-ethylmaleimide.
Childers SR
J Pharmacol Exp Ther; 1984 Sep; 230(3):684-91. PubMed ID: 6088761
[TBL] [Abstract][Full Text] [Related]
9. Effect of N-ethylmaleimide treatment on naloxone binding in frog brain membranes.
Zawilska J; Lajtha A; Borsodi A
Acta Biochim Biophys Hung; 1989; 24(1-2):33-9. PubMed ID: 2575315
[TBL] [Abstract][Full Text] [Related]
10. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
11. [Characterization of opioid receptor from bullfrog brain].
Makimura M; Ito Y; Murakoshi Y
Yakubutsu Seishin Kodo; 1988 Jun; 8(2):359-66. PubMed ID: 2851236
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):159-65. PubMed ID: 10734165
[TBL] [Abstract][Full Text] [Related]
13. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
14. Competitive displacement binding assay on rat brain sections and using a beta-imager: application to mu-opioid ligands.
Poisnel G; Quentin T; Barré L; Coquerel A; Debruyne D
J Neurosci Methods; 2006 Jun; 154(1-2):60-7. PubMed ID: 16423409
[TBL] [Abstract][Full Text] [Related]
15. Regional modulation of [3H]forskolin binding in the rat brain by guanylyl-5'-imidodiphosphate and sodium fluoride: comparison with the distribution of guanine nucleotide binding sites.
Gehlert DR
J Pharmacol Exp Ther; 1986 Dec; 239(3):952-8. PubMed ID: 3795054
[TBL] [Abstract][Full Text] [Related]
16. Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain.
Fitzgerald LW; Teitler M
Synapse; 1993 Jun; 14(2):154-9. PubMed ID: 8392757
[TBL] [Abstract][Full Text] [Related]
17. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
[TBL] [Abstract][Full Text] [Related]
18. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
Itzhak Y; Hiller JM; Simon EJ
Mol Pharmacol; 1985 Jan; 27(1):46-52. PubMed ID: 3965930
[TBL] [Abstract][Full Text] [Related]
19. Evidence for chemical differentiation of delta opioid receptor subtypes by the sulfhydryl reagent N-ethylmaleimide.
Tam L; Rafferty MF
Receptor; 1994; 4(2):81-91. PubMed ID: 7950982
[TBL] [Abstract][Full Text] [Related]
20. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
